Chemotherapy: Open Access
Open Access
ISSN: 2167-7700
+44 1223 790975
ISSN: 2167-7700
+44 1223 790975
Xiaojian Zhu
Tongji Hospital, Tongji Medical College,
No.1095 Jiefang Road, Wuhan
IR Iran
Short Communication
Future Perspectives of Tyrosine Kinase Inhibitors Discontinuation in Chronic Myeloid Leukemia
Author(s): Caibao Jin, Qing Li, Xiaojian Zhu and Li MengCaibao Jin, Qing Li, Xiaojian Zhu and Li Meng
Stopping tyrosine kinase inhibitors (TKIs) treatment is an emerging goal of chronic myeloid leukemia (CML) management. Several studies have demonstrated the feasibility of stopping treatment. A sustained molecular response on long-term TKIs therapy seems to be necessary prior to attempting treatment-free remission (TFR). However, there were none available characteristics or indicators which can predict the outcome of TKIs discontinuation now. In our opinion, factors which could reflex the progression probability of minimal residual leukemia such as leukemia stem cells and microenvironment might play a pivotal role. Besides, novel methods for further monitoring would also attract much attention of the researchers in this area.
.. View More»
DOI:
10.4172/2167-7700.1000222